Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report.
Citation:
Hamilton, J.E., Alexander, M., Kelleher, F.C., Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report, Clinical Sarcoma Research, 2020 Nov 28;10(1):25. doi:Download Item:
Abstract:
Background: Encephalopathy is an established side effect of the chemotherapeutic agent, ifosfamide, occurring in 10-30% of cases. The EEG commonly shows non-specific features of encephalopathy, and rarely shows frontal intermittent rhythmic delta activity (FIRDA).
Case presentation: This is a case report of a 71 year old woman with pleomorphic sarcoma, who developed ifosfamide-induced encephalopathy with her second dose of ifosfamide. It shows the characteristic EEG findings that have been described previously with ifosfamide-induced encephalopathy and additionally the unusual and rare finding of FIRDA. This was followed up by a further EEG showing resolution of the encephalopathy, after administration of methylene blue, coinciding with rapid and complete resolution of her symptoms.
Conclusion: The rapid resolution of the encephalopathy on the EEG after administration of methylene blue adds further evidence to its effectiveness as a treatment for the disorder.
Author's Homepage:
http://people.tcd.ie/fkellehe
Author: Kelleher, Fergal
Type of material:
Journal ArticleCollections
Series/Report no:
Clinical Sarcoma Research;10;
25;
Availability:
Full text availableSubject:
Encephalopathy, Frontal rhythmic intermittent delta activity FIRDA, Ifosfamide, Methylene blueSubject (TCD):
CancerDOI:
https://doi.org/10.1186/s13569-020-00147-3Metadata
Show full item recordThe following license files are associated with this item: